Hetero debuts semaglutide generic in emerging markets
New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…
Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India
Emcure Pharma becomes the first Indian company to hold exclusive rights to distribute and commercialise Poviztra, a semaglutide injection 2.4 mg for weight loss, the statement said. New Delhi: Novo…
Weight loss drug ‘Ozempic’ approved for use in India: What we need to know about its health benefits and risks
India has officially approved the use of Ozempic (semaglutide), a once-a-week injection designed for adults with type 2 diabetes. Approved by the Central Drugs Standard Control Organisation (CDSCO), this drug…
Lilly launches Mounjaro KwikPen in India
Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…
Biocon Bets Big on Insulin, Eyes GLP-1 Drugs for Future Growth
Bengaluru – Biocon Biologics, the biopharmaceutical arm of Biocon Ltd, is strengthening its foothold in the global insulin market while making a decisive move into the booming GLP-1 drug segment.…
Lupin Ramps Up Strategy to Counter U.S. Tariff Threat, Posts 52% Profit Surge
Mumbai, August 7, 2025 — Indian pharmaceutical giant Lupin is drawing up a multi-pronged strategy to navigate the looming threat of U.S. tariffs, while celebrating a robust 52% year-on-year surge…
HC-ordered expert panel for weight loss drug may be set up by mid-July
The Central Drugs Standard Control Organization (CDSCO) is likely to begin work on forming a court-ordered expert panel to study the unregulated use of weight loss drugs by mid-July, according…
Dr Reddy’s gears up for weight loss drug study
Dr Reddy’s Laboratories has got a go-head from the Subject Expert Committee (SEC) under India’s drug regulatory authority to conduct a bioequivalence study required to establish the safety and efficacy of the blockbuster weight…
